What is NDC 30698-006?

30698-006 is the product NDC for Trental (pentoxifylline), Pentoxifylline 400 mg/1 tablet, extended release, listed with the FDA by Validus Pharmaceuticals LLC. It has 3 package NDCs, shown above in 10- and 11-digit form.

Validus Pharmaceuticals LLC, NDC labeler code 30698. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Trental?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Trental NDC 30698-006 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)30698-006Labeler and product segments. Claims need a package NDC.

Product NDC at billing width30698-0006Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
30698-006-01	30698000601	30 TABLET, EXTENDED RELEASE in 1 BOTTLE (30698-006-01)Marketed from Oct 1, 2026
30698-006-02	30698000602	100 TABLET, EXTENDED RELEASE in 1 BOTTLE (30698-006-02)Marketed from Oct 1, 2026
30698-006-03	30698000603	500 TABLET, EXTENDED RELEASE in 1 BOTTLE (30698-006-03)Marketed from Oct 1, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Trental
Generic name (nonproprietary): pentoxifylline
Active ingredients: Pentoxifylline — 400 mg/1
Dosage form: Tablet, Extended release
Route: Oral
Labeler: Validus Pharmaceuticals LLCNDC labeler code 30698
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 018631
Marketing start: Oct 1, 2026
Listing expires: Dec 31, 2027
Other FDA classes: Hematologic Activity Alteration (Physiologic effect)
Identifiers: Product ID 30698-006_5b329d9b-a63d-78d7-e063-6294a90a2032SPL ID 5b329d9b-a63d-78d7-e063-6294a90a2032
Pharmacologic class: Blood Viscosity Reducer

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N430698000601 followed by a unit qualifier and the quantity

Package 30698-0006-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

About NDC 30698-006

What is NDC 30698-006?: 30698-006 is the product NDC for Trental (pentoxifylline), Pentoxifylline 400 mg/1 tablet, extended release, listed with the FDA by Validus Pharmaceuticals LLC. It has 3 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Trental (Pentoxifylline).
What is the active ingredient?: Pentoxifylline.
Who is the labeler?: Validus Pharmaceuticals LLC, NDC labeler code 30698. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Trental?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other NDCs under NDA 018631

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 018631
Product	Strength	Form · route	Labeler	Product NDC
Pentoxifylline	Pentoxifylline 400 mg/1	TabletOral	Advagen Pharma Ltd.,	72888-268

Trental (Pentoxifylline) NDC 30698-006